News
Roche Holdings AG Basel ADR Common Stock (OTCMKTS: RHHBY) Actemra/RoActemra obtains U.S. FDA Disaster Use Approval
July 1, 2021 |
|
DRP Gazette
News From The Wall Street Grapevine
FDA Archive
Marijuana
Medical Marijuana Inc.’s (OTCMKTS:MJNA) Subsidiary Announces Encouraging Validcare Study Results on CBD Liver Toxicity
April 1, 2021 |
|
Marijuana
The FDA Grants 22nd Century Group Inc.’s (NYSEAMERICAN:XXII) MRTP Candidate, VLN® Authorization
December 25, 2020 |
|
Featured
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Reports Topline Results From Connect-FX Clinical Study In Q2 2020: Raises $27.9 Million
September 1, 2020 |
|
Marijuana
CypCap Of Pharmacyte Biotech Inc (OTCMKTS:PMCB) Passes All The Tests In A Three Months Stability Study
July 28, 2020 |
|
Marijuana
Revive Therapeutics Ltd (OTCMKTS:RVVTF) Bets On Bucillamine, A Promising Treatment For Coronavirus: Preparing To Submit An IND With The FDA
June 30, 2020 |
|